Impact BioMedical Inc.
IBO
$0.78
$0.3268.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 119.35% | -134.57% | -1,517.47% | -31.70% | -2,094.98% |
| Total Depreciation and Amortization | 14,200.00% | 42,700.00% | 100.00% | -50.00% | 100.00% |
| Total Amortization of Deferred Charges | -- | -303.58% | 2.88% | 1.44% | -0.72% |
| Total Other Non-Cash Items | -122.75% | 109.76% | 4,570.98% | 50.00% | 101,080.77% |
| Change in Net Operating Assets | 231.31% | 130.22% | 109.52% | 83.33% | -175.18% |
| Cash from Operations | 110.04% | 38.76% | -80.26% | -41.49% | -127.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00% | -100.00% | -- | -100.00% |
| Cash from Investing | -- | 0.00% | -100.00% | -- | -100.00% |
| Total Debt Issued | -41.96% | -- | -- | -- | 36.64% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -134.38% | -- | -- | -- | 36.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.65% | -122.96% | -- | -68,200.00% | -234.50% |